RVL Pharmaceuticals plc Annual Nonoperating Income (Expense) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
RVL Pharmaceuticals plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2022.
  • RVL Pharmaceuticals plc Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $371K, a 376% increase year-over-year.
  • RVL Pharmaceuticals plc Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $6.95M, a 39.8% increase year-over-year.
  • RVL Pharmaceuticals plc annual Nonoperating Income (Expense) for 2022 was $6.26M.
  • RVL Pharmaceuticals plc annual Nonoperating Income (Expense) for 2021 was -$1.33M, a 2677% decline from 2020.
  • RVL Pharmaceuticals plc annual Nonoperating Income (Expense) for 2020 was -$48K, a 105% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6.26M +$7.6M Jan 1, 2022 Dec 31, 2022 10-K 2023-03-20
2021 -$1.33M -$1.29M -2677% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$48K -$1.04M -105% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $995K +$331K +49.8% Jan 1, 2019 Dec 31, 2019 8-K 2021-09-08
2018 $664K +$5.19M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$4.52M Jan 1, 2017 Dec 31, 2017 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.